Lenox Wealth Advisors’s Biogen BIIB Stock Holding History

Lenox Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$5K	Sell	21 -6	-22%	-$1.3K	﹤0.01%	554
2021 Q4	$6K	Buy	27 +10	+59%	+$2.57K	﹤0.01%	568
2021 Q3	$5K	Hold	17	–	–	﹤0.01%	549
2021 Q2	$6K	Hold	17	–	–	﹤0.01%	526
2021 Q1	$5K	Sell	17 -1	-6%	-$270	﹤0.01%	491
2020 Q4	$4K	Buy	18 +1	+6%	+$258	﹤0.01%	525
2020 Q3	$5K	Hold	17	–	–	﹤0.01%	437
2020 Q2	$5K	Sell	17 -3	-15%	-$902	﹤0.01%	426
2020 Q1	$6K	Sell	20 -1	-5%	-$303	﹤0.01%	394
2019 Q4	$6K	Sell	21 -19	-48%	-$5.27K	﹤0.01%	458
2019 Q3	$9K	Sell	40 -30	-43%	-$6.99K	﹤0.01%	367
2019 Q2	$16K	Sell	70 -23	-25%	-$5.31K	﹤0.01%	237
2019 Q1	$22K	Hold	93	–	–	﹤0.01%	190
2018 Q4	$28K	Hold	93	–	–	0.01%	169
2018 Q3	$33K	Hold	93	–	–	0.01%	168
2018 Q2	$27K	Sell	93 -8	-8%	-$2.25K	0.01%	218
2018 Q1	$28K	Buy	101 +84	+494%	+$26.1K	0.01%	225
2017 Q4	$5K	Buy	+17	New	+$5.45K	﹤0.01%	213
2016 Q1	–	Sell	-14	Closed	-$4K	–	271
2015 Q4	$4K	Hold	14	–	–	﹤0.01%	241
2015 Q3	$4K	Hold	14	–	–	﹤0.01%	279
2015 Q2	$6K	Hold	14	–	–	﹤0.01%	192
2015 Q1	$6K	Hold	14	–	–	﹤0.01%	210
2014 Q4	$5K	Buy	+14	New	+$4.53K	﹤0.01%	236

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Lenox Wealth Advisors's BIIB Position: Q1 2022 in Review

Lenox Wealth Advisors reduced its Biogen (BIIB) stake by 22% in Q1 2022, selling an estimated $1.3K and leaving 21 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Lenox Wealth Advisors first reported a position in BIIB in Q4 2014 and has held it in 23 quarters since. The position peaked at $33K in Q3 2018. 953 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Lenox Wealth Advisors held 21 shares of Biogen worth $5K as of Q1 2022.
Lenox Wealth Advisors sold 6 Biogen shares in Q1 2022, an estimated $1.3K.
Biogen made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #554 holding.
Lenox Wealth Advisors first reported a position in Biogen in Q4 2014 and has held it in 23 quarters since.
Lenox Wealth Advisors's Biogen position peaked at $33K in Q3 2018.
953 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.